These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31663730)

  • 1. Targeting Regorafenib-Induced Toxicity through Inhibition of Gut Microbial β-Glucuronidases.
    Ervin SM; Hanley RP; Lim L; Walton WG; Pearce KH; Bhatt AP; James LI; Redinbo MR
    ACS Chem Biol; 2019 Dec; 14(12):2737-2744. PubMed ID: 31663730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens.
    Ervin SM; Li H; Lim L; Roberts LR; Liang X; Mani S; Redinbo MR
    J Biol Chem; 2019 Dec; 294(49):18586-18599. PubMed ID: 31636122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, function, and inhibition of drug reactivating human gut microbial β-glucuronidases.
    Biernat KA; Pellock SJ; Bhatt AP; Bivins MM; Walton WG; Tran BNT; Wei L; Snider MC; Cesmat AP; Tripathy A; Erie DA; Redinbo MR
    Sci Rep; 2019 Jan; 9(1):825. PubMed ID: 30696850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering the Microbial Enzymes Driving Drug Toxicity with Activity-Based Protein Profiling.
    Jariwala PB; Pellock SJ; Goldfarb D; Cloer EW; Artola M; Simpson JB; Bhatt AP; Walton WG; Roberts LR; Major MB; Davies GJ; Overkleeft HS; Redinbo MR
    ACS Chem Biol; 2020 Jan; 15(1):217-225. PubMed ID: 31774274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy.
    Bhatt AP; Pellock SJ; Biernat KA; Walton WG; Wallace BD; Creekmore BC; Letertre MM; Swann JR; Wilson ID; Roques JR; Darr DB; Bailey ST; Montgomery SA; Roach JM; Azcarate-Peril MA; Sartor RB; Gharaibeh RZ; Bultman SJ; Redinbo MR
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7374-7381. PubMed ID: 32170007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amentoflavone from Selaginella tamariscina as a potent inhibitor of gut bacterial β-glucuronidase: Inhibition kinetics and molecular dynamics stimulation.
    Tian XG; Yan JK; Sun CP; Li JX; Ning J; Wang C; Huo XK; Zhao WY; Yu ZL; Feng L; Lv X; Ma XC
    Chem Biol Interact; 2021 May; 340():109453. PubMed ID: 33785314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics.
    Simpson JB; Walker ME; Sekela JJ; Ivey SM; Jariwala PB; Storch CM; Kowalewski ME; Graboski AL; Lietzan AD; Walton WG; Davis KA; Cloer EW; Borlandelli V; Hsiao YC; Roberts LR; Perlman DH; Liang X; Overkleeft HS; Bhatt AP; Lu K; Redinbo MR
    Cell Host Microbe; 2024 Jun; 32(6):925-944.e10. PubMed ID: 38754417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three structurally and functionally distinct β-glucuronidases from the human gut microbe
    Pellock SJ; Walton WG; Biernat KA; Torres-Rivera D; Creekmore BC; Xu Y; Liu J; Tripathy A; Stewart LJ; Redinbo MR
    J Biol Chem; 2018 Nov; 293(48):18559-18573. PubMed ID: 30301767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metagenomics combined with activity-based proteomics point to gut bacterial enzymes that reactivate mycophenolate.
    Simpson JB; Sekela JJ; Graboski AL; Borlandelli VB; Bivins MM; Barker NK; Sorgen AA; Mordant AL; Johnson RL; Bhatt AP; Fodor AA; Herring LE; Overkleeft H; Lee JR; Redinbo MR
    Gut Microbes; 2022; 14(1):2107289. PubMed ID: 35953888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse Gut Microbiome-Encoded β-Glucuronidases Identified Using Metagenome Analysis Guided by Protein Structure.
    Creekmore BC; Gray JH; Walton WG; Biernat KA; Little MS; Xu Y; Liu J; Gharaibeh RZ; Redinbo MR
    mSystems; 2019 Aug; 4(4):. PubMed ID: 31455640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insights into microbial β-glucuronidase inhibition to abrogate CPT-11 toxicity.
    Roberts AB; Wallace BD; Venkatesh MK; Mani S; Redinbo MR
    Mol Pharmacol; 2013 Aug; 84(2):208-17. PubMed ID: 23690068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Atlas of β-Glucuronidases in the Human Intestinal Microbiome.
    Pollet RM; D'Agostino EH; Walton WG; Xu Y; Little MS; Biernat KA; Pellock SJ; Patterson LM; Creekmore BC; Isenberg HN; Bahethi RR; Bhatt AP; Liu J; Gharaibeh RZ; Redinbo MR
    Structure; 2017 Jul; 25(7):967-977.e5. PubMed ID: 28578872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regorafenib.
    Ettrich TJ; Seufferlein T
    Recent Results Cancer Res; 2014; 201():185-96. PubMed ID: 24756792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regorafenib.
    Ettrich TJ; Seufferlein T
    Recent Results Cancer Res; 2018; 211():45-56. PubMed ID: 30069758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity.
    Wallace BD; Roberts AB; Pollet RM; Ingle JD; Biernat KA; Pellock SJ; Venkatesh MK; Guthrie L; O'Neal SK; Robinson SJ; Dollinger M; Figueroa E; McShane SR; Cohen RD; Jin J; Frye SV; Zamboni WC; Pepe-Ranney C; Mani S; Kelly L; Redinbo MR
    Chem Biol; 2015 Sep; 22(9):1238-49. PubMed ID: 26364932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regorafenib: a novel multitargeted tyrosine kinase inhibitor for colorectal cancer and gastrointestinal stromal tumors.
    Crona DJ; Keisler MD; Walko CM
    Ann Pharmacother; 2013 Dec; 47(12):1685-96. PubMed ID: 24259629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae.
    Little MS; Pellock SJ; Walton WG; Tripathy A; Redinbo MR
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E152-E161. PubMed ID: 29269393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentinan as a natural stabilizer with bioactivities for preparation of drug-drug nanosuspensions.
    Suo Z; Sun Q; Peng X; Zhang S; Gan N; Zhao L; Yuan N; Zhang Y; Li H
    Int J Biol Macromol; 2021 Aug; 184():101-108. PubMed ID: 34119545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition and structure-activity relationship of dietary flavones against three Loop 1-type human gut microbial β-glucuronidases.
    Wang P; Wu R; Jia Y; Tang P; Wei B; Zhang Q; Wang VY; Yan R
    Int J Biol Macromol; 2022 Nov; 220():1532-1544. PubMed ID: 36096258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amoxapine Demonstrates Incomplete Inhibition of β-Glucuronidase Activity from Human Gut Microbiota.
    Yang W; Wei B; Yan R
    SLAS Discov; 2018 Jan; 23(1):76-83. PubMed ID: 28809607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.